Table 2.

Anticoagulation complication comparison with NOACs for LAAC.

	Rivaroxaban (n = 82)	Dabigatran (n = 38)	p value	OR (95% CI)
Bleeding complications
Gastrointestinal hemorrhage (%)	4 (4.9%)	2 (5.3%)	0.928	0.927 (0.177-4.842)
Operation site hemorrhage (%)	2 (2.4%)	1 (2.6%)	0.950	0.927 (0.087-9.909)
Skin ecchymosis (%)	3 (3.7%)	2 (5.3%)	0.682	0.695 (0.121-3.990)
Laboratory parameters
PLT < 125 (%)	7 (8.5%)	3 (7.9%)	0.906	1.081 (0.296-3.954)
Male: Hb < 120 (%)	4 (4.9%)	1 (2.6%)	0.567	1.854 (0.214-16.030)
Female: Hb < 110 (%)

OR: odds ratio; CI: confidence interval; PLT: platelet count; Hb: hemoglobin.